Professional Summary
Professional Overview
James Pan is an accomplished biotechnology executive with extensive experience in drug discovery, development, and commercialization. He is a strategic leader with a proven track record in driving innovation and delivering impactful results in the pharmaceutical and life sciences industries.
Current Role
James is currently serving as the Chief Executive Officer at BriSTAR Immunotech, a leading biopharmaceutical company focused on the development of novel immunotherapies. In this role, he is responsible for setting the strategic vision, leading cross-functional teams, and driving the company's growth and success in the highly competitive biotech landscape.
Career Progression
Prior to his current position, James held several senior-level roles that have shaped his extensive industry expertise. He served as the Head of Discovery and Development at Exacis Biotherapeutics, where he led the advancement of cutting-edge therapeutic candidates. James also previously held the position of Scientific Advisor at ImmunoBiochem Corporation, where he provided strategic guidance and technical expertise to support the company's research and development initiatives.
Earlier in his career, James held various leadership roles, including Vice President of Research & Product Development at The Centre for the Commercialization of Antibodies and Biologics, and Scientific Leader for therapeutic antibody programs at the University of Toronto. He also gained valuable experience as the Head of Drug Discovery and Research at the Campbell Family Institute for Breast Cancer Research, Princess Margaret Hospital, UHN, and as an Investigator in Oncology, Kidney Fibrosis, and Inflammation at Genentech.
Academic Background
James holds a Ph.D. in Molecular Biology and Immunology from the University of Michigan, where he was a Research Fellow of the Leukemia & Lymphoma Society (LLS). His academic achievements and specialized training have equipped him with a deep understanding of the scientific principles and cutting-edge technologies that drive advancements in the biotechnology and pharmaceutical industries.
Areas of Expertise
James's expertise spans various areas, including therapeutic antibody development, drug discovery and optimization, preclinical and clinical trial design, and regulatory strategy. He is a skilled leader with a strong background in managing cross-functional teams, fostering collaborative partnerships, and driving organizational growth and innovation.
Professional Impact
Throughout his career, James has made significant contributions to the biotechnology and pharmaceutical industries. He has led the development of several promising drug candidates, spearheaded the commercialization of innovative therapeutic platforms, and actively participated in industry associations and scientific conferences, sharing his insights and driving advancements in the field.
Conclusion
With his exceptional technical expertise, strategic leadership, and proven track record of success, James Pan is poised to continue making substantial contributions to the biotechnology industry. His commitment to innovation and his ability to translate scientific discoveries into viable commercial products make him a valuable asset to any organization seeking to drive transformative change in the healthcare landscape.
